Overview
Riikka Karjalainen practices in Helsinki, Finland. Karjalainen is rated as an Experienced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Their top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myeloproliferative Neoplasms (MPN), and Multiple Myeloma.
Their clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Karjalainen isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaKarjalainen isAdvanced. Learn about Leukemia.
- Experienced
- Essential ThrombocythemiaKarjalainen isExperienced. Learn about Essential Thrombocythemia.
- Multiple MyelomaKarjalainen isExperienced. Learn about Multiple Myeloma.
- MyelofibrosisKarjalainen isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Karjalainen isExperienced. Learn about Myeloproliferative Neoplasms (MPN).